glutathione disulfide has been researched along with Stomach Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Choromańska, A; Drąg-Zalesińska, M; Kulbacka, J; Kulbacki, M; Rembiałkowska, N; Rossowska, J; Szewczyk, A | 1 |
| Kravchenko, OO; Ostapchenko, LI; Sokur, OV; Tymoshenko, MO | 1 |
| Abe, M; Hatakeyama, K; Kami, K; Kinugasa, Y; Kusuhara, M; Mochizuki, T; Sugino, T; Terashima, M; Yamaguchi, K; Yamakawa, Y | 1 |
3 other study(ies) available for glutathione disulfide and Stomach Neoplasms
| Article | Year |
|---|---|
Nanosecond PEF Induces Oxidative Stress and Apoptosis via Proteasomal Activity Inhibition in Gastric Adenocarcinoma Cells with Drug Resistance.
Topics: Adenocarcinoma; Apoptosis; Calcium; Drug Resistance; Electroporation; Glutathione Disulfide; Humans; Oxidative Stress; Reactive Oxygen Species; Stomach Neoplasms | 2022 |
The phospho-c-Jun (Ser63) content in mucosa cells under experimental development of gastric cancer.
Topics: Animals; Cells, Cultured; Gastric Mucosa; Glutathione; Glutathione Disulfide; Immunoenzyme Techniques; JNK Mitogen-Activated Protein Kinases; Male; Methylnitronitrosoguanidine; Phosphorylation; Rats; Stomach Neoplasms | 2014 |
CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected tissues.
Topics: Aged; Biomarkers, Tumor; Female; Glutathione; Glutathione Disulfide; Humans; Hyaluronan Receptors; Male; Metabolome; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Reactive Oxygen Species; Stomach Neoplasms; Survival Rate | 2017 |